Related Experiment Video
Updated: Jan 28, 2026

Emergency Undocking in Robotic Surgery: A Simulation Curriculum
Published on: May 20, 2018
Current and emerging pharmacotherapy for the treatment of infections following open-heart surgery
Daniele Roberto Giacobbe1, Silvia Corcione2, Antonio Salsano3,4
1a Dipartimento di Scienze della Salute (DISSAL) , University of Genoa , Genoa , Italy.
Introduction:
Patients undergoing open-heart surgery may suffer from postoperative complications, including severe infections. Antimicrobials to treat infectious complications in this population should be selected thoughtfully, taking into account three different and fundamental issues: (i) the site of infection; (ii) the suspected or proven causative agent and its susceptibility pattern; and (iii) the risk of suboptimal pharmacokinetic characteristics and potential toxicity of the chosen drug/s.
Areas Covered:
The present narrative review summarizes the current and future antimicrobial options for the treatment of infections developing after open-heart surgery.
Expert Opinion:
The pharmacological treatment of infections developing in cardiac surgery patients poses peculiar challenges, including the need for an active empirical therapy for severe events such as bloodstream infections, deep sternal wound infections, or early-onset postoperative prosthetic endocarditis. In addition, the risk for multidrug-resistant pathogens should also be taken into account in endemic areas. A multidisciplinary evaluation on a patient-by-patient basis, deeply involving infectious diseases specialists and cardiothoracic surgeons, remains essential for appropriately balancing both short-term and long-term risks and benefits of any possible surgical reintervention in combination with adequate pharmacotherapy.
Insights
Choosing antimicrobials for open-heart surgery patients requires careful consideration of infection site, pathogen susceptibility, and drug pharmacokinetics to prevent complications. This review covers current and future antimicrobial strategies for these complex infections.
Area of Science:
- Cardiology
- Infectious Diseases
- Pharmacology
Background:
- Open-heart surgery patients are at high risk for severe postoperative infections.
- Antimicrobial selection is complex due to infection site, pathogen resistance, and drug properties.
Purpose of the Study:
- To review current and future antimicrobial options for treating infections after open-heart surgery.
- To address challenges in antimicrobial therapy for cardiac surgery patients.
Main Methods:
- Narrative review of existing literature.
- Analysis of antimicrobial treatment strategies.
Main Results:
- Empirical therapy is crucial for severe infections like bloodstream infections and deep sternal wounds.
- Multidrug-resistant pathogens pose a significant threat in endemic areas.
Conclusions:
- Multidisciplinary collaboration between infectious diseases specialists and cardiothoracic surgeons is essential.
- Balancing risks and benefits of pharmacotherapy and potential reintervention is critical.
More Related Videos
04:05Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
03:47A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
Published on: October 25, 2024
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Emerging Adulthood
Introduction Cardiac Emergencies
Anatomy of the Heart
Electrical Current